| Financial Year |
March 31 2023 |
| Monetary Funds |
4,134,260,491.76 |
| Held-for-trading Financial Assets |
413,910,699.20 |
| Notes Receivable |
-- |
| Accounts Receivable |
868,789,359.50 |
| Advances to Suppliers |
1,541,709,781.38 |
| Other Receivables |
1,418,252,060.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
509,239,455.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,367,855,807.70 |
| Other Current Assets |
297,128,356.08 |
| Total Current Assets |
12,551,347,896.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
203,221,892.42 |
| Long-term Equity Investment |
91,295,046.47 |
| Investment Properties |
3,084,136,037.98 |
| Fixed Assetes |
280,752,334.18 |
| Under-construction Projects |
1,441,128.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,107,192,544.30 |
| R&D expenses |
95,669,060.20 |
| Goodwill |
4,811,545,713.61 |
| Long-Term Deferred and Prepaid Expenses |
598,057,132.88 |
| Deferred Income Tax Assets |
689,649,674.08 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
20,273,860,059.71 |
| Total Assets |
32,825,207,956.15 |
| Short-Term Loans |
2,155,176,685.62 |
| Trading Financial liabilities |
-- |
| Notes Payable |
71,897,400.00 |
| Accounts Payable |
342,778,474.57 |
| Accounts Received In Advance |
664,670,398.74 |
| Employee Compensation Payable |
405,491,097.31 |
| Taxes Payable |
1,125,898,238.27 |
| Interest Payable |
-- |
| Dividend Payable |
651,574.07 |
| Other payables |
1,325,619,852.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,411,483,842.81 |
| Other Current Liabilities |
43,718,962.60 |
| Sub-Total of Current Liabilities |
17,277,269,469.08 |
| Long-term Loans |
522,372,310.69 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
501,027.94 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
698,329,355.39 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,100,967,534.24 |
| Total Liabilities |
22,378,237,003.32 |
| Paid-In Capital(Or Share Stock) |
2,355,500,851.00 |
| Capital Surplus |
5,442,818,873.49 |
| Surplus Reserve |
131,292,712.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,094,554,817.22 |
| Minority Stockholder's Interest |
92,728,339.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,354,242,613.75 |
| Owner's Equity（Stockholder's Equity） |
10,446,970,952.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
32,825,207,956.15 |
